Article

Interrelationship between COVID-19 and coagulopathy: pathophysiological and clinical evidence

2023-04-27

Abstract excerpt

Since the first description of COVID-19 infection, among clinical manifestations of the disease including fever, dispnea, cough, fatigue, it was observed a high incidence of thromboembolic events potentially evolving towars ARDS and COVID-associated-coagulopathy (CAC).The hypercoagulation state is based on an interaction between thrombosis and inflammation. The so-called CAC represents a key aspect in the genesis...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: b372ca07-3667-58f2-bf8b-be2761dd1acc
DOI: 10.20944/preprints202304.1030.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Interrelationship between COVID-19 and coagulopathy: pathophysiological and clinical evidenceDOI 10.20944/preprints202304.1030.v1Read

Systemic inflammation in COVID-19 patients may induce various types of venous and arterial thrombosis: A systematic review.Semantic proximity Read

Coagulation Status and Venous Thromboembolism Risk in African Americans: A Potential Risk Factor in COVID-19.Semantic proximity Read

Covid-19-associated coagulopathy (CoAC): thrombin burst and insufficient fibrinolysis leading to bad outcome.Semantic proximity Read

Severity-stratified and longitudinal analysis of VWF/ADAMTS13 imbalance, altered fibrin crosslinking and inhibition of fibrinolysis as contributors to COVID-19 coagulopathySemantic proximity Read

Prothrombotic Phenotype in COVID-19: Focus on Platelets.Semantic proximity Read

SARS-CoV-2 Spike protein promotes vWF secretion and thrombosis via endothelial cytoskeleton-associated protein 4 (CKAP4)Semantic proximity Read

COVID-19 Sepsis: Pathogenesis and Endothelial Molecular Mechanisms Based on "Two-Path Unifying Theory" of Hemostasis and Endotheliopathy-Associated Vascular Microthrombotic Disease, and Proposed Therapeutic Approach with Antimicrothrombotic Therapy.Semantic proximity Read

Plasma biomarkers associated with survival and thrombosis in hospitalized COVID-19 patientsSemantic proximity Read

<strong></strong><strong>COVID-19 Clot: What Is It? Why in the Lungs? Extracellular Histone, “Auto-Activation” of Prothrombin, Emperipolesis, Megakaryocytes, “Self-Association” of Von Willebrand Factor and Beyond</strong>Semantic proximity Read

Anti-phospholipids antibodies and immune complexes in COVID-19 patients: a putative role in disease course for anti-annexin-V antibodiesSemantic proximity Read

Inflammatory response in relation to COVID-19 and other prothrombotic phenotypes.Semantic proximity Read

The viral accelerated NF-κB pathway drives COVID-19-associated coagulopathy via excessive transcription of tissue factor and plasminogen activator inhibitor 1 – case reportSemantic proximity Read